These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 17509734

  • 1. The preclinical testing of a formaldehyde inactivated Ross River virus vaccine designed for use in humans.
    Kistner O, Barrett N, Brühmann A, Reiter M, Mundt W, Savidis-Dacho H, Schober-Bendixen S, Dorner F, Aaskov J.
    Vaccine; 2007 Jun 15; 25(25):4845-52. PubMed ID: 17509734
    [Abstract] [Full Text] [Related]

  • 2. Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: a randomized trial.
    Aichinger G, Ehrlich HJ, Aaskov JG, Fritsch S, Thomasser C, Draxler W, Wolzt M, Müller M, Pinl F, Van Damme P, Hens A, Levy J, Portsmouth D, Holzer G, Kistner O, Kreil TR, Barrett PN.
    Vaccine; 2011 Nov 21; 29(50):9376-84. PubMed ID: 22001875
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of an inactivated Ross River virus vaccine in active and passive mouse immunization models and establishment of a correlate of protection.
    Holzer GW, Coulibaly S, Aichinger G, Savidis-Dacho H, Mayrhofer J, Brunner S, Schmid K, Kistner O, Aaskov JG, Falkner FG, Ehrlich H, Barrett PN, Kreil TR.
    Vaccine; 2011 May 31; 29(24):4132-41. PubMed ID: 21477673
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. An inactivated Ross River virus vaccine is well tolerated and immunogenic in an adult population in a randomized phase 3 trial.
    Wressnigg N, van der Velden MV, Portsmouth D, Draxler W, O'Rourke M, Richmond P, Hall S, McBride WJ, Redfern A, Aaskov J, Barrett PN, Aichinger G.
    Clin Vaccine Immunol; 2015 Mar 31; 22(3):267-73. PubMed ID: 25540268
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A candidate Ross River virus vaccine: preclinical evaluation.
    Aaskov J, Williams L, Yu S.
    Vaccine; 1997 Mar 31; 15(12-13):1396-404. PubMed ID: 9302751
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Detection by ELISA of IgM antibodies to Ross River virus in serum from patients with suspected epidemic polyarthritis.
    Oseni RA, Donaldson MD, Dalglish DA, Aaskov JG.
    Bull World Health Organ; 1983 Mar 31; 61(4):703-8. PubMed ID: 6313247
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus.
    Kumar M, Sudeep AB, Arankalle VA.
    Vaccine; 2012 Sep 21; 30(43):6142-9. PubMed ID: 22884660
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of an In-Frame Deletion of the 6k Gene Locus from the Genome of Ross River Virus.
    Taylor A, Melton JV, Herrero LJ, Thaa B, Karo-Astover L, Gage PW, Nelson MA, Sheng KC, Lidbury BA, Ewart GD, McInerney GM, Merits A, Mahalingam S.
    J Virol; 2016 Apr 21; 90(8):4150-4159. PubMed ID: 26865723
    [Abstract] [Full Text] [Related]

  • 13. Sucrose density gradient centrifugation and cross-flow filtration methods for the production of arbovirus antigens inactivated by binary ethylenimine.
    Pyke AT, Phillips DA, Chuan TF, Smith GA.
    BMC Microbiol; 2004 Jan 14; 4():3. PubMed ID: 14720306
    [Abstract] [Full Text] [Related]

  • 14. A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses.
    Spruth M, Kistner O, Savidis-Dacho H, Hitter E, Crowe B, Gerencer M, Brühl P, Grillberger L, Reiter M, Tauer C, Mundt W, Barrett PN.
    Vaccine; 2006 Jan 30; 24(5):652-61. PubMed ID: 16214268
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Molecular evolutionary dynamics of Ross River virus and implications for vaccine efficacy.
    Jones A, Lowry K, Aaskov J, Holmes EC, Kitchen A.
    J Gen Virol; 2010 Jan 30; 91(Pt 1):182-8. PubMed ID: 19759236
    [Abstract] [Full Text] [Related]

  • 17. [Study on a purified and inactivated Japanese encephalitis vaccine prepared on Vero cells using SA14-14-2 attenuated virus strain].
    Yao Z, Dong G, Yu Y.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Jun 30; 13(2):191-3. PubMed ID: 12569794
    [Abstract] [Full Text] [Related]

  • 18. Potency analysis of inactivated vaccines for Aujeszky's disease virus (ADV), strain RC/79: lymphocyte stimulation in immunized pigs.
    Sabini LI, Ceriatti F, Torres C, Sutil S, Lara L, Rovera M, Ramos B, Rodriguez MI.
    Rev Latinoam Microbiol; 2001 Jun 30; 43(3):123-9. PubMed ID: 17061498
    [Abstract] [Full Text] [Related]

  • 19. An inactivated West Nile virus vaccine for domestic geese-efficacy study and a summary of 4 years of field application.
    Samina I, Khinich Y, Simanov M, Malkinson M.
    Vaccine; 2005 Sep 30; 23(41):4955-8. PubMed ID: 16023273
    [Abstract] [Full Text] [Related]

  • 20. Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses.
    Swenson DL, Warfield KL, Larsen T, Alves DA, Coberley SS, Bavari S.
    Expert Rev Vaccines; 2008 May 30; 7(4):417-29. PubMed ID: 18444889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.